Kuo CS - Search Results

1

Correlation Between mRNA Expression of Activated Eosinophils and Air Pollutant Exposure in Patients With Asthma.

Lin TY, Chang PJ, Lo CY, Chuang HC, Lee CS, Chang CH, Yu CT, Hsieh MH, Liu CY, Kuo CS, Lin SM. Lin TY, et al. Among authors: kuo cs. Immun Inflamm Dis. 2024 Nov;12(11):e70065. doi: 10.1002/iid3.70065. Immun Inflamm Dis. 2024. PMID: 39575691 Free PMC article.

2

Cardiorespiratory coupling is associated with exercise capacity in patients with chronic obstructive pulmonary disease.

Huang YC, Lin TY, Wu HT, Chang PJ, Lo CY, Wang TY, Kuo CS, Lin SM, Chung FT, Lin HC, Hsieh MH, Lo YL. Huang YC, et al. Among authors: kuo cs. BMC Pulm Med. 2021 Jan 12;21(1):22. doi: 10.1186/s12890-021-01400-1. BMC Pulm Med. 2021. PMID: 33435937 Free PMC article.

3

Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab.

Ko HW, Chiu CT, Wang CL, Yang TY, Liu CY, Yu CT, Tseng LC, Kuo CS, Wang CC, Yang MH, Yang CT. Ko HW, et al. Among authors: kuo cs. Cancers (Basel). 2022 Jul 17;14(14):3470. doi: 10.3390/cancers14143470. Cancers (Basel). 2022. PMID: 35884531 Free PMC article.

4

Front-line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control.

Huang SH, Huang AC, Wang CC, Chang WC, Liu CY, Pavlidis S, Ko HW, Chung FT, Hsu PC, Guo YK, Kuo CS, Yang CT. Huang SH, et al. Among authors: kuo cs. Thorac Cancer. 2019 Dec;10(12):2274-2281. doi: 10.1111/1759-7714.13221. Epub 2019 Oct 15. Thorac Cancer. 2019. PMID: 31613427 Free PMC article.

5

A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed.

Kuo CS, Tung PH, Huang AC, Wang CC, Chang JW, Liu CY, Chung FT, Fang YF, Guo YK, Yang CT. Kuo CS, et al. BMC Cancer. 2021 Mar 24;21(1):309. doi: 10.1186/s12885-021-08005-1. BMC Cancer. 2021. PMID: 33761908 Free PMC article.

6

Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR-mutant and EGFR-wild type nonsquamous non-small cell lung cancer.

Huang YC, Shen SM, Liu CY, Pavlidis S, Wang CL, Ko HW, Chung FT, Lin TY, Feng PH, Lee KY, Guo YK, Yang CT, Kuo CS. Huang YC, et al. Among authors: kuo cs. Thorac Cancer. 2018 Dec;9(12):1648-1655. doi: 10.1111/1759-7714.12875. Epub 2018 Sep 27. Thorac Cancer. 2018. PMID: 30259696 Free PMC article.

7

Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non-small cell lung cancer.

Kuo CS, Wang CC, Huang YC, Pavlidis S, Liu CY, Ko HW, Chung FT, Lin TY, Wang CL, Guo YK, Yang CT. Kuo CS, et al. Thorac Cancer. 2019 May;10(5):1158-1166. doi: 10.1111/1759-7714.13057. Epub 2019 Apr 5. Thorac Cancer. 2019. PMID: 30950239 Free PMC article.

8

Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer.

Chu CH, Chiu TH, Wang CC, Chang WC, Huang AC, Liu CY, Wang CL, Ko HW, Chung FT, Hsu PC, Guo YK, Kuo CS, Yang CT. Chu CH, et al. Among authors: kuo cs. Thorac Cancer. 2020 Jun;11(6):1541-1549. doi: 10.1111/1759-7714.13426. Epub 2020 Apr 13. Thorac Cancer. 2020. PMID: 32281272 Free PMC article.

9

First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer.

Huang AC, Huang CH, Ju JS, Chiu TH, Tung PH, Wang CC, Liu CY, Chung FT, Fang YF, Guo YK, Kuo CS, Yang CT. Huang AC, et al. Among authors: kuo cs. Ther Adv Med Oncol. 2021 Jul 31;13:17588359211035710. doi: 10.1177/17588359211035710. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34377157 Free PMC article.

10

Afatinib treatment in a large real-world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation.

Huang CH, Ju JS, Chiu TH, Huang AC, Tung PH, Wang CC, Liu CY, Chung FT, Fang YF, Guo YK, Kuo CS, Yang CT. Huang CH, et al. Among authors: kuo cs. Int J Cancer. 2022 Feb 15;150(4):626-635. doi: 10.1002/ijc.33821. Epub 2021 Oct 26. Int J Cancer. 2022. PMID: 34558665

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters